BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $41.00

BrightSpring Health Services (NASDAQ:BTSG) had its target price lifted by Bank of America from $38.00 to $41.00 in a research note published on Tuesday,Benzinga reports. Bank of America currently has a buy rating on the stock.

Several other equities research analysts have also commented on the stock. Mizuho set a $38.00 target price on shares of BrightSpring Health Services in a research report on Wednesday, October 29th. Jefferies Financial Group set a $36.00 price objective on shares of BrightSpring Health Services and gave the company a “buy” rating in a research note on Tuesday, October 21st. UBS Group boosted their price objective on shares of BrightSpring Health Services from $35.00 to $42.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Wall Street Zen cut shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 15th. Finally, William Blair assumed coverage on shares of BrightSpring Health Services in a research report on Monday. They set an “outperform” rating for the company. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $38.18.

BrightSpring Health Services Stock Performance

NASDAQ BTSG opened at $35.90 on Tuesday. The stock has a market capitalization of $6.47 billion, a price-to-earnings ratio of 58.85, a PEG ratio of 0.61 and a beta of 2.36. The business’s 50 day moving average is $32.83 and its two-hundred day moving average is $26.58. BrightSpring Health Services has a 12-month low of $15.26 and a 12-month high of $36.77. The company has a current ratio of 1.79, a quick ratio of 1.38 and a debt-to-equity ratio of 1.36.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Monday, October 20th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. BrightSpring Health Services had a return on equity of 11.61% and a net margin of 1.04%.The business had revenue of $3.33 billion during the quarter, compared to analysts’ expectations of $3.16 billion. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. Research analysts expect that BrightSpring Health Services will post 0.59 EPS for the current year.

Insider Buying and Selling at BrightSpring Health Services

In other news, insider Lisa A. Nalley sold 20,000 shares of the business’s stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total value of $575,600.00. Following the completion of the transaction, the insider directly owned 131,150 shares of the company’s stock, valued at $3,774,497. The trade was a 13.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Jon B. Rousseau sold 235,000 shares of the company’s stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total value of $6,763,300.00. Following the completion of the sale, the insider owned 1,131,930 shares in the company, valued at $32,576,945.40. This represents a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.40% of the company’s stock.

Institutional Investors Weigh In On BrightSpring Health Services

Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of BrightSpring Health Services by 6.4% during the third quarter. Vanguard Group Inc. now owns 9,604,703 shares of the company’s stock worth $283,915,000 after buying an additional 576,906 shares in the last quarter. Invesco Ltd. raised its position in shares of BrightSpring Health Services by 2.5% in the 3rd quarter. Invesco Ltd. now owns 9,347,125 shares of the company’s stock worth $276,301,000 after buying an additional 227,717 shares during the period. T. Rowe Price Investment Management Inc. lifted its stake in shares of BrightSpring Health Services by 264.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company’s stock valued at $104,430,000 after purchasing an additional 4,189,805 shares in the last quarter. Alliancebernstein L.P. lifted its position in BrightSpring Health Services by 12.1% during the second quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company’s stock valued at $128,568,000 after buying an additional 588,642 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in BrightSpring Health Services by 936.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,276,583 shares of the company’s stock worth $53,705,000 after purchasing an additional 2,056,920 shares during the period.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.